Posts filtered by tags: Andrew Dunn[x]


 

A massive study from Israel suggests older adults were far less likely to develop severe COVID-19 after a booster shot, but the finding carries major limitations

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP A third dose of Pfizer's coronavirus vaccine dramatically reduces the risk of infection and severe illness for older adults, a new study found. A team of researchers in Israel published the findings Wednesday in The New England Journal of Medicine. Still, an expert urged caution on interpreting the findings, saying the study...
Tags: Health, Science, News, Israel, US, Trends, Healthcare, Food And Drug Administration, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, Murray, New England Journal of Medicine, Tel Aviv Israel


Beyond COVID-19 vaccines, mRNA's pioneers have big plans for using the technology against a range of diseases

BI Graphics Employees in special suits test procedures for manufacturing the messenger RNA (mRNA) COVID-19 vaccine from Pfizer-BioNTech, in Marburg, Germany. Abdulhamid Hosbas/Anadolu Agency via Getty Images Drugmakers big and small are storming into messenger RNA research. The technology behind the first COVID-19 vaccines could help fight other diseases, including cancer. Early leaders in the mRNA space include Moderna, BioNTech, Pfizer, Sanofi, and GlaxoSmitKline. This artic...
Tags: Massachusetts, Trends, University of Pennsylvania, GlaxoSmithKline, Pfizer, Epstein Barr, Sanofi, GSK, Chikungunya, Rockville Maryland, Paul Hudson, Moderna, Andrew Dunn, Stéphane Bancel, BioNtech, COVID


FDA releases documents outlining Pfizer's case for COVID-19 booster shots

Vials of the Pfizer-BioNTech Covid-19 vaccine. Patrick Fallon/AFP via Getty Images The FDA released documents Wednesday giving a look at Pfizer's case for COVID-19 booster shots. The data shows a third dose of Pfizer's shot raised antibody levels with no major safety concerns. An expert panel will make recommendations to the FDA on booster shots on Friday. See more stories on Insider's business page. The US Food and Drug Administration published documents on Wednesday that prov...
Tags: Health, UK, Science, News, Cdc, Trends, Healthcare, Delta, Fda, Pfizer, Biotech, Biden, Centers For Disease Control And Prevention, US Food and Drug Administration, Pharmaceutical, Andrew Dunn


The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data

President Joe Biden speaks about prescription drug prices and his "Build Back Better" agenda from the East Room of the White House, Thursday, Aug. 12, 2021, in Washington. Associated Press/Evan Vucci The heads of the FDA and CDC are pushing back on the White House's plan for COVID-19 booster shots. The top health officials say they need more time to review data on extra doses, . It's the latest setback to the Biden administration's booster plan, which has also prompted resigna...
Tags: Health, Science, News, Cdc, White House, US, Trends, Joe Biden, Healthcare, The Times, Fda, Pfizer, Biotech, Biden, Times, Johnson Johnson


What's ahead for COVID-19 drugs and vaccines in 2021

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:The 10 big events to pay attention to when it comes to COVID-19 vaccines and treatments;We broke down where the top biotechs (according to VCs) are based;Find out why One Medical made its $1.4 billion bet on Iora. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...As you might expect, there'll be ...
Tags: Boston, Medical, Los Angeles, Trends, Mit, Healthcare, Medicare, Pfizer, Biotech, Vaccines, Elizabeth Holmes, Bay Area, Andrew, Newsletters, Treatments, Andrew Dunn


Why experts think life will get better by 2023 - if enough people get vaccinated

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and I'm catching up after taking some time off to hike the Grand Canyon from rim to rim.This week in healthcare news:The FDA approved Pfizer's coronavirus vaccine - but the pandemic endgame isn't here yet;We've got interactive maps and quizzes that break down the biotech industry;Why experts think it'll take more than technology to diversify clinical trials. If you're new to this newsletter, sign up here....
Tags: US, Trends, Mit, Getty Images, Healthcare, Miami, Fda, Pfizer, Biotech, Vaccines, Nih, Grand Canyon, Mckinsey, Andrew, Big Pharma, Malik


Pfizer's CEO tell us why he thinks we'll need COVID-19 vaccines every year, like flu shots

Albert Bourla, CEO of Pfizer Crystal Cox/Skye Gould/Insider People will most likely need annual COVID-19 booster shots, Pfizer CEO Albert Bourla told Insider. It's another sign that we'll be dealing with the novel coronavirus for years to come. The pharma exec highlighted the risk of new variants emerging and vaccine protection waning. See more stories on Insider's business page. Pfizer CEO Albert Bourla predicted in a Wednesday interview that people will most likely need annua...
Tags: Health, Science, News, US, Trends, Healthcare, Food And Drug Administration, World Health Organization, Fda, Pfizer, Pharmaceutical, Moderna, Andrew Dunn, Albert Bourla, Bourla, Hilary Brueck


The FDA just fully approved Pfizer's COVID-19 vaccine in a move that could lead to more vaccinations

Pfizer BioNTech's COVID-19 vaccine. Pete Bannan/MediaNews Group/Daily Local News via Getty Images The FDA has fully approved Pfizer-BioNTech's coronavirus vaccine. The two-dose shot is now the first and only COVID-19 vaccine to get full approval. The shot was previously OK'd under emergency-use authorization, a more flexible regulatory standard. See more stories on Insider's business page. The US Food and Drug Administration issued the first full approval Monday for a coron...
Tags: New York, US, Trends, Goldman Sachs, Fda, Pfizer, Getty, Usa Today, Anthony Fauci, Johnson Johnson, US Food and Drug Administration, Fauci, Kaiser Family Foundation, Moderna, Janet Woodcock, Andrew Dunn


Apple and Google face setbacks in healthcare

Hello,Welcome to Insider Healthcare. I'm Andrew Dunn rounding up this week's healthcare news:Apple is scaling back a key health project and Google is ending Google Health;The Biden administration says COVID-19 booster shots will start in September;We profiled 30 leaders of the healthcare industry under the age of 40. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @AndrewE_Dunn. Dr. Sumbul Desai, M.D., a VP of health at Apple...
Tags: Apple, Google, Washington Post, Cdc, US, Trends, Food And Drug Administration, Silicon Valley, Fda, Biden, Blake, Hugh, Google Amazon, Eddie Martucci, Akili Interactive, Paul Offit


One chart shows how well COVID-19 vaccines protect you against the Delta variant

Pulmonology physician Catherine Wentowski treats a coronavirus patient at the Ochsner Medical Center in Jefferson Parish, Louisiana, August 10, 2021. Kathleen Flynn/Reuters The Delta variant is driving a surge in US coronavirus cases and hospitalizations. Although Delta can partially evade vaccine-induced antibodies, vaccines work against it. One chart shows how well four vaccines prevent symptomatic Delta infections, severe illness, and death. See more stories on Insider's business pa...
Tags: Health, UK, Science, News, Cdc, White House, Israel, US, Tel Aviv, Trends, Delta, Food And Drug Administration, Astrazeneca, Pfizer, University of Oxford, Biden


The Biden administration will start rolling out COVID-19 vaccine boosters in September, offering most people another shot 8 months after vaccination

Getty Most people in the US will be offered a COVID-19 booster shot about eight months after vaccination. The plan aims to better protect Americans from the coronavirus amid a surge driven by the Delta variant. Some experts have said there isn't yet data showing that we need booster shots. See more stories on Insider's business page. The Biden administration rolled out its plan Wednesday for giving booster shots of the COVID-19 vaccine, saying most people in the US will be offere...
Tags: US, Trends, Delta, Pfizer, Biden, Jefferies, Johnson Johnson, US Food and Drug Administration, Pompano Beach Florida, Moderna, Michael Yee, Andrew Dunn, Stéphane Bancel, COVID, Vera Leip, Moderna About


Delta's surging and antibodies are waning: What to know about when we'll need COVID-19 booster shots

Moderna has soared over the past year on the back of its coronavirus vaccine. Radek Mica/Getty Images Should the US start offering people an extra COVID-19 vaccines dose? Supporters cite signs of waning protection and data suggesting a booster shot would help. Others say boosting now is unnecessary, because the shots still prevent hospitalizations and death. See more stories on Insider's business page. The debate over whether the US should roll out extra doses of coronavirus vaccines...
Tags: Health, Science, Cdc, France, Germany, Israel, Nbc News, US, Trends, Analysis, Healthcare, Delta, World Health Organization, Philadelphia, Fda, Pfizer


The FDA signed off on COVID-19 booster shots for immunocompromised people

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:The FDA signs off on COVID-19 booster shots for immunocompromised people;Meet the new potential dealmakers of the drug industry;Three ways Dollar General could get into healthcare. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Registered Nurse Robert Orallo administers the Pfizer Covid-19 va...
Tags: US, Trends, Healthcare, Fda, Biotech, Vaccines, Bayer, Andrew, Anchorage, Bayer AG, Big Pharma, US Israel, Newsletters, Frederic J Brown, Dollar General, Noubar Afeyan


Vaccines are seatbelts, not armor

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We got a reminder that "vaccines, they're not magic";The 24 biotech startups top VCs say are poised to take off;Check out the presentation Yelp for holistic-care startup Kensho used to raise its seed round. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Marianne Ayala/Insider Rethink...
Tags: US, Newsletter, Trends, Healthcare, Delta, Vaccine, Andreessen Horowitz, Biotech, HIPAA, Moderna, Andrew Dunn, RTW Investments, Avery Hartmans, Hilary Brueck, Aria Bendix, Yeji Jesse Lee


Moderna says we'll need COVID-19 booster shots this fall, predicting protection will wane from its vaccine

Moderna CEO Stephane Bancel attends a meeting with President Donald Trump, members of the Coronavirus Task Force, and pharmaceutical executives in the Cabinet Room of the White House on March 2, 2020. Andrew Harnik/AP Images Moderna expects people will need to get a third dose of its COVID-19 vaccine before this winter. Going out eight months, Moderna executives said the vaccine's protection is waning. "We believe a booster dose is likely to be necessary this fall," Moderna President ...
Tags: France, White House, Germany, Israel, Trends, Delta, Food And Drug Administration, World Health Organization, Pfizer, The New York Times, Times, Donald Trump, Hoge, Paul Offit, Moderna, Cabinet Room


Israel will roll out a booster dose of the Pfizer-BioNTech COVID-19 vaccine to older people, citing a drop in protection against severe disease driven by the Delta variant

An Israeli receives a coronavirus vaccine from medical staff at a COVID-19 vaccination center in Tel Aviv, Israel, Wednesday, Jan. 6, 2021. Sebastian Scheiner/AP Israel will begin offering booster shots of Pfizer's coronavirus vaccine this weekend. The vaccine's protection against severe illness waned over time from 97% to 81%, officials said. With the rise of the Delta variant, many countries are considering booster doses. See more stories on Insider's business page. Israel w...
Tags: UK, New York, Israel, US, Trends, Delta, Pfizer, Tel Aviv Israel, Eric Topol, Andrew Dunn, Sebastian Scheiner, Scripps Research Translational Institute


What could become the next big cancer treatment

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We found the drugmakers that are all going after the same potential cancer treatment;A CB Insights report shed light on the newest unicorns and top corporate investor so far this year;We took a closer look at some of the new approaches companies have been taking to tackle mental and behavioral health - especially for youth. If you're new to this newsletter, sign up here. Tips, comments? Email...
Tags: Apple, US, Trends, Walmart, Healthcare, VCs, Digital Health, Behavioral Health, Andrew, UnitedHealth Group, Big Pharma, Megan, Newsletters, Akili, Kevin Lynch, Cancer Immunotherapy


Why health insurers big and small are investing in delivering care

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:Why insurers big and small are investing in delivering care;We looked at how the Delta variant is impacting case counts here in the US - and how vaccine-makers are responding;See the pitch deck a startup used to win over investors on an idea that could shape the next wave of telehealth. If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @l...
Tags: Cdc, Medical, US, Trends, Healthcare, Delta, Fda, Pfizer, Vaccines, Clover, Humana, Johnson Johnson, UnitedHealth, Lilly, Shelby, Newsletters


We got a look inside Moderna's labs

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this (short) week in healthcare news:We traveled to Moderna's labs in Norwood to check out the biotech's work on miniaturizing vaccine development;We learned that Amazon has been pitching Amazon Care to health insurers including Aetna;We took a look at who owns medical practices these days - and how some insurers are doing it from the start.If you're new to this newsletter, sign up here. Tips, comments? Email me ...
Tags: Amazon, US, Trends, Healthcare, Norwood, Amazon Web Services, Northeastern University, Shelby, Jade, Andy Jassy, Aetna, Newsletters, Northwell Health, Norwood Massachusetts, Primary Care, Moderna


Hot upstart insurer Bright Health stumbles in its stock-market debut

Hello,Welcome to Insider Healthcare. I'm Shelby Livingston, and this week in healthcare news:Rapidly growing Bright Health became the latest upstart insurer to make its stock-market debut;We looked at the nine primary-care companies rushing to upend how we go to the doctor;Doctors stand to make thousands on a controversial new Alzheimer's drug.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @ShelbyJLiv. Let's get to it....
Tags: Ipo, America, Trends, Getty Images, Healthcare, Alzheimer's, Fda, Fairfax Media, SPAC, UnitedHealth Group, Biogen, Newsletters, Primary Care, Bright Health, Andrew Dunn, Mohana


A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs

Hi, Good morning, and welcome back to Insider Healthcare. I'm Andrew Dunn, and today in healthcare news:A new Alzheimer's drug exposes a 'fundamentally flawed' part of how the US pays for drugs;The US will likely miss Biden's July 4 vaccination goal;GlaxoSmithKline faces a critical investor day as activist investor pressure increases.If you're new to this newsletter, sign up here. And let me know what we should be paying attention to going forward: [email protected] On t...
Tags: Europe, White House, US, America, Trends, Getty Images, Alzheimer's Disease, Healthcare, Fda, GlaxoSmithKline, Pfizer, Biden, Fairfax Media, Chadwick Boseman, Elliott, GSK


CureVac's COVID-19 shot just failed in a large trial, a major setback for the Gates-backed biotech

An employee of German biopharmaceutical company CureVac. REUTERS/Andreas Gebert CureVac's experimental COVID-19 vaccine failed in a pivotal clinical study, the biotech said Wednesday. It's the first late-stage study to flop, with CureVac's vaccine showing 47% effectiveness. The German biotech saw its stock price drop by more than 50% in post-market trading. See more stories on Insider's business page. A COVID-19 vaccine candidate developed by the German biotech CureVac f...
Tags: Health, Science, Trends, Healthcare, Vaccine, Biotech, Bill Melinda Gates Foundation, CureVac, Andrew Dunn, Coronavirus, COVID, Dispensed, Andreas Gebert, Franz Werner Haas


Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use

lechatnoir/Getty Images Novavax said its coronavirus vaccine was 90% effective at preventing COVID-19. The shot succeeded in a study that enrolled almost 30,000 volunteers in the US and Mexico. The Maryland biotech plans to ask US regulators for permission to give the shot more widely. See more stories on Insider's business page. The biotech company Novavax said on Monday that its coronavirus vaccine succeeded in a final-stage clinical trial, demonstrating 90% efficacy at preventing...
Tags: Health, UK, Science, News, Maryland, Mexico, US, Trends, South Africa, Healthcare, Astrazeneca, Biotech, Johnson Johnson, Pharmaceutical, Novavax, Gaithersburg Maryland


What a controversial drug approval could mean for future Alzheimer's treatments

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:A controversial Alzheimer's drug approval poses some big challenges for the future of the field;We chronicled the history of Noom, which raised $540 million from top investors after spending a decade trying to crack the weight-loss app business;Amazon and Walmart face off on discounting prescriptions.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected]
Tags: Amazon, Newsletter, Trends, Walmart, Alzheimer's Disease, Healthcare, Food And Drug Administration, Fda, Morgan Stanley, Silver Lake, Pharmacy, Shelby, Megan, Allison, Gabby, Biogen


Young people are experiencing rare cases of heart inflammation after getting coronavirus vaccines, but doctors say the risk of COVID-19 is far greater

Pfizer BioNTech's COVID-19 vaccine at Desert Valley Hospital. Irfan Khan / Los Angeles Times via Getty Images Young people who receive COVID-19 vaccines are reporting higher rates of heart inflammation, a possible side effect. The CDC is investigating a potential link between Pfizer and Moderna shots and these events. Even if there is a link, doctors said the risk is far greater from COVID-19 than from the vaccines. See more stories on Insider's business page. Young people who rece...
Tags: Cdc, Israel, US, Trends, Food And Drug Administration, University of Pennsylvania, Pfizer, Centers For Disease Control And Prevention, Rubin, Northwell Health, Paul Hennessy, Melbourne Florida, Cohen Children s Medical Center, Moderna, Andrew Dunn, COVID


What we still don't know about vaccines

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We outlined the questions we still have about coronavirus vaccines;There's one big question surrounding synthetic biology company Ginkgo as it plans to go public;What's at stake as activists and companies go head-to-head over the future of psychedelics.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's ge...
Tags: UK, Washington, US, Los Angeles, Trends, Healthcare, Vaccines, Madison, Ginkgo Bioworks, Chamath Palihapitiya, Babylon, Don, SPAC, Allison, Newsletters, Mario Tama Getty


What's shaking up the future of the retail pharmacy

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:Blake Dodge's scoop on Amazon's bricks-and-mortar pharmacy ambitions shook up healthcare stocks;Dealmaking is heating up heading into the summer - for biotech and digital health;How Wall Street is betting on primary care companies.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it...First, I hop...
Tags: Amazon, Trends, Healthcare, M&a, Biotech, Digital Health, Bessemer, Pharmacy, Kelly, Blake, Miami Florida, Allison, Newsletters, Akili, Moderna, Could Amazon


Moderna says its coronavirus vaccine is effective in teens, and the biotech plans to apply in early June for an expanded OK

A coronavirus vaccine trial volunteer receives a shot. Glenn Asakawa/University of Colorado Moderna's coronavirus vaccine likely works in teens, according to study results that the biotech plans to submit to regulators next month. The vaccine could become the second OK'd for people as young as 12. Teens in Moderna's study had similar immune responses as adults who received the shot. See more stories on Insider's business page. Moderna's coronavirus vaccine appears to be...
Tags: Health, Science, News, Massachusetts, Trends, Healthcare, Pfizer, Biotech, US Food and Drug Administration, Pharmaceutical, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine, Dispensed


What's at stake for the next wave of coronavirus vaccines

Hello,Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and this week in healthcare news:We looked at how the next set of COVID-19 vaccine candidates are shaping up;A consolidation tsunami is headed for digital healthcare;We found 5 key takeaways from Bright Health's IPO filing.If you're new to this newsletter, sign up here. Tips, comments? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it... Kate Bingham, Chair of the Government's Vaccine...
Tags: London, Ipo, US, Trends, Healthcare, Food And Drug Administration, GlaxoSmithKline, Vaccine, Digital Health, Cb Insights, Acquisitions, Jpmorgan, Andrew, Blake, Sanofi, Allison


Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program's potential as a booster shot

Sanofi CEO Paul Hudson Reuters Sanofi and GlaxoSmithKline said that their experimental COVID-19 vaccine succeeded in a mid-stage trial. The pharma giants plan to launch a pivotal-stage study with 35,000 volunteers in the coming weeks. The shot suffered from disappointing data and delays in 2020. The companies now hope for approval by year's end. See more stories on Insider's business page. One of the world's most closely watched coronavirus vaccine programs reported positive d...
Tags: Health, Science, Microsoft, US, Trends, Healthcare, GlaxoSmithKline, Johnson Johnson, Sanofi, GSK, Pharmaceutical, Andrew Dunn, Emma Walmsley, Coronavirus, Coronavirus Vaccine, Dispensed